245 related articles for article (PubMed ID: 7833483)
1. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.
Sintnicolaas K; van Marwijk Kooij M; van Prooijen HC; van Dijk BA; van Putten WL; Claas FH; Novotny VM; Brand A
Blood; 1995 Feb; 85(3):824-8. PubMed ID: 7833483
[TBL] [Abstract][Full Text] [Related]
2. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
van Marwijk Kooy M; van Prooijen HC; Moes M; Bosma-Stants I; Akkerman JW
Blood; 1991 Jan; 77(1):201-5. PubMed ID: 1984797
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study.
Novotny VM; van Doorn R; Witvliet MD; Claas FH; Brand A
Blood; 1995 Apr; 85(7):1736-41. PubMed ID: 7703481
[TBL] [Abstract][Full Text] [Related]
4. Prevention of refractoriness and HLA-alloimmunization using filtered blood products.
Sniecinski I; O'Donnell MR; Nowicki B; Hill LR
Blood; 1988 May; 71(5):1402-7. PubMed ID: 3282572
[TBL] [Abstract][Full Text] [Related]
5. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial.
Oksanen K; Kekomäki R; Ruutu T; Koskimies S; Myllylä G
Transfusion; 1991 Sep; 31(7):588-94. PubMed ID: 1891788
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
Trial to Reduce Alloimmunization to Platelets Study Group
N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
[TBL] [Abstract][Full Text] [Related]
7. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].
Handa M; Ikeda Y; Kurata Y; Tsubaki K; Horiuchi A; Furihata K; Kimura Y; Toyama K; Takamoto S; Tsukimoto I
Rinsho Ketsueki; 1992 Apr; 33(4):451-60. PubMed ID: 1602608
[TBL] [Abstract][Full Text] [Related]
9. Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions.
Brand A; Claas FH; Voogt PJ; Wasser MN; Eernisse JG
Vox Sang; 1988; 54(3):160-6. PubMed ID: 3369136
[TBL] [Abstract][Full Text] [Related]
10. [Refractory effect and alloimmunization after transfusion of thrombocytes].
Volkova RI; Agranenko VA
Gematol Transfuziol; 1992 Feb; 37(2):16-21. PubMed ID: 1426903
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of platelet transfusion refractoriness and HLA alloimmunization by leukocyte filtered platelet transfusion: a meta analysis].
Yuan Q; Chen X; Cheng L; Zhou CH; Fu XM; Li YP; Wang NH; Wang L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Aug; 33(4):412-20. PubMed ID: 21906451
[TBL] [Abstract][Full Text] [Related]
12. Pretransplant platelet transfusion refractoriness is not associated with platelet nonengraftment in T-replete hematopoietic progenitor cell transplantation for hematologic malignancies.
Scott A; Baidya S; Butler J; Morris K; Thornton A; Kennedy GA
Transfusion; 2016 Jan; 56(1):164-9. PubMed ID: 26264674
[TBL] [Abstract][Full Text] [Related]
13. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.
Hogge DE; McConnell M; Jacobson C; Sutherland HJ; Benny WB; Massing BG
Transfusion; 1995 Aug; 35(8):645-52. PubMed ID: 7631404
[TBL] [Abstract][Full Text] [Related]
14. Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration.
Andreu G; Dewailly J; Leberre C; Quarre MC; Bidet ML; Tardivel R; Devers L; Lam Y; Soreau E; Boccaccio C
Blood; 1988 Sep; 72(3):964-9. PubMed ID: 3416079
[TBL] [Abstract][Full Text] [Related]
15. [Development of HLA antibodies in thrombocyte substitution with cell separator products].
Koepsell E; Zumpe P; Saavedra C; Seidl S
Beitr Infusionsther; 1992; 30():416-9. PubMed ID: 1284749
[TBL] [Abstract][Full Text] [Related]
16. Refractoriness to platelet transfusions in children with acute leukemia.
DeCoteau J; Haddad S; Blanchette V; Poon A
J Pediatr Hematol Oncol; 1995 Nov; 17(4):306-10. PubMed ID: 7583385
[TBL] [Abstract][Full Text] [Related]
17. Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management.
Panch SR; Guo L; Vassallo R
Blood Rev; 2023 Nov; 62():101135. PubMed ID: 37805287
[TBL] [Abstract][Full Text] [Related]
18. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
Wong M; Narra R; Selim M; Zimmerman MA; Kim J; Padmanabhan A; Hong JC
J Surg Res; 2020 Nov; 255():99-105. PubMed ID: 32543385
[TBL] [Abstract][Full Text] [Related]
19. In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice.
Poston JN; Jash A; Hannan LM; Hay AM; Usaneerungrueng C; Howie HL; Kapp LM; Zimring JC
Transfusion; 2021 Mar; 61(3):687-691. PubMed ID: 33336414
[TBL] [Abstract][Full Text] [Related]
20. Systematic use of leukocyte-free blood components to prevent alloimmunization and platelet refractoriness in multitransfused children with cancer.
Saarinen UM; Koskimies S; Myllylä G
Vox Sang; 1993; 65(4):286-92. PubMed ID: 8310680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
